Shares of Ekso Bionics Holdings (NASDAQ:EKSO) increased in after-market trading after the company reported Q1 results.

Quarterly Results

Earnings per share rose 22.73% year over year to ($0.34), which missed the estimate of ($0.24).

Revenue of $1,910,000 up by 30.11% year over year, which missed the estimate of $3,000,000.

Guidance

Ekso Bionics Holdings hasn't issued any earnings guidance for the time being.

Ekso Bionics Holdings hasn't issued any revenue guidance for the time being.

Details Of The Call

Date: Apr 29, 2021

Time: 04:30 PM

ET Webcast URL: https://78449.themediaframe.com/dataconf/productusers/ekso/mediaframe/44362/indexl.html

Technicals

Company's 52-week high was at $14.98

52-week low: $2.80

Price action over last quarter: down 27.27%

Company Profile